Back to Search
Start Over
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
- Source :
-
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2000 Aug; Vol. 15 (8), pp. 1459-66. - Publication Year :
- 2000
-
Abstract
- Osteoclast formation in bone is supported by osteoblasts expressing receptor activator of NF-kappa B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) expression. Numerous osteotropic factors regulate expression levels of RANKL and the RANKL decoy receptor osteoprotegerin (OPG) in osteoblasts, thereby affecting osteoclast differentiation. However, not only in RANKL widely expressed in soft tissues, but osteoclasts have been noted in extraskeletal lesions. We found that cultured skin fibroblastic cells express RANKL, M-CSF, and OPG messenger (mRNA). Stimulation by 1 alpha,25 dihydroxyvitamin D3 [1,25(OH)2D3] plus dexamethasone (Dex) augmented RANKL and diminished OPG mRNA expression in fibroblastic cells and caused the formation of numerous osteoclasts in cocultures of skin fibroblastic cells with hemopoietic cells or monocytes. The osteoclasts thus formed expressed tartrate-resistant acid phosphatase (TRAP) and calcitonin (CT) receptors and formed resorption pits in cortical bone. Osteoclast formation also was stimulated (in the presence of Dex) by prostaglandin E2 (PGE2), interleukin-11 (IL-11), IL-1, tumor necrosis factor-alpha (TNF-alpha), and parathyroid hormone-related protein (PTHrP), factors which also stimulate osteoclast formation supported by osteoblasts. In addition, granulocyte-macrophage-CSF (GM-CSF), transforming growth factor-beta (TGF-beta), and OPG inhibited osteoclast formation in skin fibroblastic cell-hemopoietic cell cocultures; CT reduced only osteoclast nuclearity. Fibroblastic stromal cells from other tissues (lung, respiratory diaphragm, spleen, and tumor) also supported osteoclast formation. Thus, RANKL-positive fibroblastic cells in extraskeletal tissues can support osteoclastogenesis if osteolytic factors and osteoclast precursors are present. Such mesenchymally derived cells may play a role in pathological osteolysis and may be involved in osteoclast formation in extraskeletal tissues.
- Subjects :
- Animals
Calcitriol pharmacology
Cell Differentiation
Cells, Cultured
Coculture Techniques
Dexamethasone pharmacology
Gene Expression
Glycoproteins genetics
Ligands
Macrophage Colony-Stimulating Factor genetics
Mice
Osteoblasts cytology
Osteoclasts cytology
Osteoclasts metabolism
Osteoprotegerin
RANK Ligand
Receptor Activator of Nuclear Factor-kappa B
Receptors, Cytoplasmic and Nuclear genetics
Receptors, Tumor Necrosis Factor
Stromal Cells drug effects
Carrier Proteins genetics
Fibroblasts metabolism
Membrane Glycoproteins genetics
NF-kappa B metabolism
Osteoclasts physiology
Stromal Cells metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0884-0431
- Volume :
- 15
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
- Publication Type :
- Academic Journal
- Accession number :
- 10934644
- Full Text :
- https://doi.org/10.1359/jbmr.2000.15.8.1459